Clinical Trial Update: A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing cardiovascular safety of degarelix versus leuprolide in advanced prostate cancer patients with cardiovascular disease was terminated; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide (Leuprolide acetate)
• degarelix (degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2022-06-29